Login / Signup
Xun Bao
ORCID
Publication Activity (10 Years)
Years Active: 2022-2024
Publications (10 Years): 9
Top Topics
Mass Spectrometry
Cell Cycle Arrest
Signaling Pathway
Endoplasmic Reticulum Stress
Top Venues
Molecular cancer therapeutics
Biomedical chromatography : BMC
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Adrianne Wallace-Povirk
,
Carrie O'Connor
,
Aamod S Dekhne
,
Xun Bao
,
Md Junayed Nayeen
,
Mathew Schneider
,
Jade M Katinas
,
Jennifer Wong-Roushar
,
Seongho Kim
,
Lisa Polin
,
Jing Li
,
Jessica B Back
,
Charles E Dann
,
Aleem Gangjee
,
Zhanjun Hou
,
Larry H Matherly
Mitochondrial and cytosolic one-carbon metabolism is a targetable metabolic vulnerability in cisplatin-resistant ovarian cancer.
Molecular cancer therapeutics
(2024)
Adrianne Wallace-Povirk
,
Carrie O'Connor
,
Aamod S Dekhne
,
Xun Bao
,
Md Junayed Nayeen
,
Mathew Schneider
,
Jade M Katinas
,
Jennifer Wong-Roushar
,
Seongho Kim
,
Lisa Polin
,
Jing Li
,
Jessica B Back
,
Charles E Dann
,
Aleem Gangjee
,
Zhanjun Hou
,
Larry H Matherly
Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer.
Molecular cancer therapeutics
23 (6) (2024)
Adrianne Wallace-Povirk
,
Carrie O'Connor
,
Aamod S Dekhne
,
Xun Bao
,
Md Junayed Nayeen
,
Mathew Schneider
,
Jade M Katinas
,
Jennifer Wong-Roushar
,
Seongho Kim
,
Lisa Polin
,
Jing Li
,
Jessica B Back
,
Charles E Dann
,
Aleem Gangjee
,
Zhanjun Hou
,
Larry H Matherly
Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer.
Molecular cancer therapeutics
23 (6) (2024)
Adrianne Wallace-Povirk
,
Carrie O'Connor
,
Aamod S Dekhne
,
Xun Bao
,
Md Junayed Nayeen
,
Mathew Schneider
,
Jade M Katinas
,
Jennifer Wong-Roushar
,
Seongho Kim
,
Lisa Polin
,
Jing Li
,
Jessica B Back
,
Charles E Dann
,
Aleem Gangjee
,
Zhanjun Hou
,
Larry H Matherly
Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer.
Molecular cancer therapeutics
23 (6) (2024)
Adrianne Wallace-Povirk
,
Carrie O'Connor
,
Aamod S Dekhne
,
Xun Bao
,
Md Junayed Nayeen
,
Mathew Schneider
,
Jade M Katinas
,
Jennifer Wong-Roushar
,
Seongho Kim
,
Lisa Polin
,
Jing Li
,
Jessica B Back
,
Charles E Dann
,
Aleem Gangjee
,
Zhanjun Hou
,
Larry H Matherly
Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer.
Molecular cancer therapeutics
23 (6) (2024)
Adrianne Wallace-Povirk
,
Carrie O'Connor
,
Aamod S Dekhne
,
Xun Bao
,
Md Junayed Nayeen
,
Mathew Schneider
,
Jade M Katinas
,
Jennifer Wong-Roushar
,
Seongho Kim
,
Lisa Polin
,
Jing Li
,
Jessica B Back
,
Charles E Dann
,
Aleem Gangjee
,
Zhanjun Hou
,
Larry H Matherly
Mitochondrial and cytosolic one-carbon metabolism is a targetable metabolic vulnerability in cisplatin-resistant ovarian cancer.
Molecular cancer therapeutics
(2024)
Adrianne Wallace-Povirk
,
Carrie O'Connor
,
Aamod S Dekhne
,
Xun Bao
,
Md Junayed Nayeen
,
Mathew Schneider
,
Jade M Katinas
,
Jennifer Wong-Roushar
,
Seongho Kim
,
Lisa Polin
,
Jing Li
,
Jessica B Back
,
Charles E Dann
,
Aleem Gangjee
,
Zhanjun Hou
,
Larry H Matherly
Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer.
Molecular cancer therapeutics
23 (6) (2024)
Adrianne Wallace-Povirk
,
Carrie O'Connor
,
Aamod S Dekhne
,
Xun Bao
,
Md Junayed Nayeen
,
Mathew Schneider
,
Jade M Katinas
,
Jennifer Wong-Roushar
,
Seongho Kim
,
Lisa Polin
,
Jing Li
,
Jessica B Back
,
Charles E Dann
,
Aleem Gangjee
,
Zhanjun Hou
,
Larry H Matherly
Mitochondrial and cytosolic one-carbon metabolism is a targetable metabolic vulnerability in cisplatin-resistant ovarian cancer.
Molecular cancer therapeutics
(2024)
Jun Jiang
,
Xun Bao
,
Yang Yue
,
David Schiff
,
Ranjit Bindra
,
Jing Li
Development and validation of a liquid chromatography coupled with tandem mass spectrometry method for determining total and unbound pamiparib in human plasma and brain tumors.
Biomedical chromatography : BMC
36 (12) (2022)